New hope for advanced skin cancers: first human trial launches
Disease control
Recruiting now
This early-stage trial tests a new drug called KUP-101A in 21 people with advanced skin cancers (like melanoma or Merkel cell carcinoma) that have not responded to standard treatments. The main goal is to find a safe dose and check for side effects. Researchers will also look at …
Phase: PHASE1 • Sponsor: Kupando GmbH • Aim: Disease control
Last updated May 26, 2026 10:01 UTC